CLINICAL_TRIALS
trial_result
· 2014-07-15
Clinical Trial Update: Plant Cell Expressed Recombinant Human Glucocerebrosidase Extension Trial [Phase 3]
Summary
Phase 3 trial update for plant cell expressed recombinant human glucocerebrosidase in Gaucher disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Gaucher Disease | Phase 3 | Status: COMPLETED | Results posted: 2014-07-15